Search Results - "Butterfield, L.H"

Development of a large-scale H3.3K27M-specific TCR-transduced T cell manufacturing method for adoptive cell therapy in HLA-A2+ patients with diffuse midline glioma by Okada, K, Nguyen, A, Watchmaker, P, Xu, J, Ramsdell, F, Esensten, J.H, Butterfield, L.H, Okada, H

“…Background & AimDiffuse midline glioma (DMG), including diffuse intrinsic pontine glioma (DIPG), constitutes up to 20% of pediatric brain cancer and has a…”
Get full text

361 Dendritic cell vaccines for metastatic melanoma by Damiano, J.J., Patrone, C.C., Falo, L.D., Butterfield, L.H., Kirkwood, J.M., Geskin, L.J.

Get full text

T Cell Assays and MIATA: The Essential Minimum for Maximum Impact by Britten, C.M., Janetzki, S., Butterfield, L.H., Ferrari, G., Gouttefangeas, C., Huber, C., Kalos, M., Levitsky, H.I., Maecker, H.T., Melief, C.J.M., O’Donnell-Tormey, J., Odunsi, K., Old, L.J., Ottenhoff, T.H.M., Ottensmeier, C., Pawelec, G., Roederer, M., Roep, B.O., Romero, P., van der Burg, S.H., Walter, S., Hoos, A., Davis, M.M.

“…[...]the current version of MIATA is a testimonial to the freedom and transparency of research and proves the ability of the research community to form…”
Get full text

Cloning and sequence analysis of candidate human natural killer-enhancing factor genes by SHAU, H, BUTTERFIELD, L. H, CHIU, R, KIM, A

“…A cytosol factor from human red blood cells enhances natural killer (NK) activity. This factor, termed NK-enhancing factor (NKEF), is a protein of 44,000 M(r)…”
Get full text

Benjamin Rush and the Beginning of John and Mary's College Over Susquehanna by BUTTERFIELD, L.H.

Get full text